Sfoglia per Autore
Preliminary classification of nonmalignant B cell proliferation in Sjögren’s syndrome: perspectives on pathobiology and treatment based on an integrated clinico-pathologic and molecular study approach. Blood Cells, Molecules and Diseases 2001; 27: 757-66 (IF 1.703)
2001-01-01 DE VITA, Salvatore; De Marchi, G; Sacco, S; Gremese, E; Fabris, M; Ferraccioli, G. F.
Non-malignant lymphoproliferation in Sjögren’s syndrome: proposed classification based on integrated clinico-pathologic and molecular studies and follow-up.
2001-01-01 DE VITA, Salvatore; Scott, Cathryn Anne; Fabris, M; Damato, R; Perin, A; Sacco, S; Ferraccioli, Gf
Nuovo inquadramento della malattia linfoproliferativa in corso di crioglobulinemia mista, e recenti sviluppi sui linfomi HCV-correlati
2001-01-01 DE VITA, Salvatore; De Re, V; Sansonno, D; Sacco, S; Fabris, M; Damato, R; Gremese, E; Perin, A; Di Poi, E; Monteverde, A; Dammacco, F; Baiocchi, M; Ferraccioli, Gf
TNF-alpha gene polymorphisms in rheumatoid arthritis patient treated with anti-TNF- alpha agents: preliminary results
2002-01-01 Fabris, Martina; Di Poi, E.; Sacco, S.; Damante, Giuseppe; Sinigaglia, L.; Ferraccioli, Gianfranco
Tumor necrosis factor-alpha gene polymorphism in severe and mild -moderate rheumatoid arthritis.
2002-01-01 Damante, Giuseppe; D'Elia, Angela Valentina; Di, Pe; Fabris, Martina; Ferraccioli, Gianfranco; Sinigaglia, L.
Fibronectin plasma levels and gene polymorphisms in aggressive RA patients treated with anti-TNF-alpha agents.
2004-01-01 Fabris, M; Tolusso, B; Sacco, S; Quartuccio, Luca; Ferraccioli, G; DE VITA, Salvatore
Fibronectin plasma levels and gene polymorphisms in aggressive RA patients treated with anti-TNF-alpha agents
2004-01-01 Fabris, M; Tolusso, B; Sacco, S; Quartuccio, Luca; Ferraccioli, G; DE VITA, Salvatore
SYSTEMIC CONNECTIVE TISSUE DISEASE COMPLICATED BY CASTLEMAN'S DISEASE: REPORT OF A CASE AND REVIEW OF THE LITERATURE
2004-01-01 DE MARCHI, G; DE VITA, Salvatore; Fabris, M; Scott, Cathryn Anne; Ferraccioli, G.
B lymphocyte stimulator (BLyS) and monocytes: possible role in autoimmune diseases with a particular reference to rheumatoid arthritis
2004-01-01 Quartuccio, Luca; Fabris, M; Ferraccioli, G.
B-Lymphocyte Stimulator (BLyS) in mixed cryoglobulinemia sindrome: pathobiological and clinical implication.
2005-01-01 Fabris, M; Sacco, S; De Marchi, G; Quartuccio, Luca; Migone, T; Pozzato, G; Mazzaro, C; Ferraccioli, G; DE VITA, Salvatore
B-Lymphocyte Stimulator (BLyS) in mixed cryoglobulinemia sindrome: pathobiological and clinical implication
2005-01-01 Fabris, M; Sacco, S; De Marchi, G; Quartuccio, Luca; Migone, T; Pozzato, G; Mazzaro, C; Ferraccioli, G; DE VITA, Salvatore
Fibronectin gene polymorphisms influence type II mixed cryoglobulinemia clinical manifestations.
2005-01-01 Fabris, M; De Marchi, G; Sacco, S; DE VITA, Salvatore
-238 AND +489 TNF-ALPHA ALONG WITH TNF-RII GENE POLYMORPHISMS ASSOCIATE WITH THE DIFFUSE PHENOTYPE IN PATIENTS WITH SYSTEMIC SCLEROSIS
2005-01-01 Tolusso, B; Fabris, M; Caporali, R; Cuomo, G; Isola, Miriam; Soldano, F; Montecucco, C; Valentini, G; Ferraccioli, G.
An Italilan multicenter controlled study of HCV-related malignancies: role of the HLA class II.
2006-01-01 De Re, V; DE VITA, Salvatore; Caggiari, L; Fabris, M; Mazzero, C; Lenzi, M; Galli, M; Monti, G; Ferri, C; Zignego, Al; Gabrielli, A; Sansonno, D; Dammmacco, F; Libra, M; Salamini, ; Simula, P; Caragnano, ; Spina, M; Cannizzaro, R; Dolcetti, R.
Studio multicentrico controllato su neoplasie correlate al HCV:ruolo dell’HLA classe II. 2006; 38 Suppl.1, O.C. 2.4.5
2006-01-01 De Re, V; DE VITA, Salvatore; Caggiari, L; Fabris, M; Mazzaro, C; Lenzi, M; Galli, M; Monti, G; Ferri, C; Zignego, Al; Gabrielli, A; Sansonno, D; Dammmacco, F; Libra, M; Salamini, ; Simula, P; Caragnano, ; Spina, M; Cannizzaro, R; Digestive, Dolcetti R. Studio multicentrico controllato su neoplasie correlate al HCV:ruolo dell’HLA classe I. I.; Liver Disease, 2006; 38, S. u. p. p. l. 1.; O. C. 2. 4., 5.
Rituximab treatment for Glomerulonephritis in HCV-associated Mixed Cryoglobulinemia: efficacy and safety in the lack of steroids
2006-01-01 Quartuccio, Luca; Soardo, G; Romano, Giulio; Zaja, F; Scott, Cathryn Anne; DE MARCHI, G; Fabris, M; Ferraccioli, G; DE VITA, Salvatore
Twist is substrate for caspase cleavage and proteasome-mediated degradation
2006-01-01 Demontis, S; Rigo, C; Piccinin, S; Mizzau, Michela; Sonego, Maura; Fabris, Martina; Brancolini, Claudio; Maestro, R.
Type II mixed cryglobulinaemia as an oligo rather than a mono B-cell disorder: evidence from GeneScan and MALDI-TOF analyses
2006-01-01 Boiocchi, M; Carbone, A; Damacco, F; DE RE, V; DE VITA, Salvatore; Fabris, Martina; Gasparotto, D; Gloghini, A; Marzotto, A; Sansonno, D; Simula, M. P.; Tucci, F. A.
Atypical lymphoproliferation progressing into B-cell lymphoma in rheumatoid arthritis treated with different biological agents: clinical course and molecular characterization.
2006-01-01 Quartuccio, Luca; De Re, V.; Fabris, M; Marzotto, A.; Franzolini, N; Gasparotto, D.; Caggiari, L.; Ferraccioli, G.; Scott, Cathryn Anne; DE VITA, Salvatore
HCV-NS3 and IgG-Fc crossreactive IGM in patients with type II mixed cryoglobulinemia and B-cell clonal proliferations
2006-01-01 De Re, V.; Sansonno, D.; Simula, M. P.; Caggiari, L.; Gasparotto, D; Fabris, M.; Tucci, F. A.; Racanelli, V.; Talamini, R; Campagnolo, M.; Geremia, S.; Dammacco, F.; De Vita, S.
Association be tween B cell clonal expansion and glomerulonephritis in type cryoglobulinnaemia
2007-01-01 Quartuccio, Luca; Fabris, M; De Marchi, G; Salvin, S; Falleti, E; DE VITA, Salvatore
Metodo diagnostico e prognostico per la diagnosi e la prognosi della linfoproliferazione nelle malattie immunomediate organo specifiche e/o di pertinenza trasfusionale
2007-01-01 Curcio, Francesco; DE VITA, Salvatore; Fabris, M; Tonutti, E; Melli, C.
Association between bone marrow B cell clonal expansion and glomerulonephritis in type II mixed cryoglobulinaemia
2007-01-01 Quartuccio, Luca; Fabris, M; Sacco, S.
Association be tween B cell clonal expansion and glomerulonephritis in type cryoglobulinnaemia. 2007; 66 (Suppl. II): 121
2007-01-01 Quartuccio, Luca; Fabris, M; De Marchi, G; Salvin, S; Falleti, E; DE VITA, Salvatore
Rituximab in mixed cryoglobulinemia: increased experience and perspectives
2007-01-01 DE VITA, Salvatore; Quartuccio, Luca; Fabris, M.
Evidence for an association between the -871 t/c promoter polymorphism in the b-lymphocyte stimulator (blys) gene and the development of an overt lymphoproliferative disorder in mixed cryoglobulinemia syndrome (mcsn).
2007-01-01 Fabris, M; Lerussi, A; Quartuccio, ; De, Marchi; DE VITA, Salvatore
LA SINDROME DI SJOGREN E LA CRIOGLOBULINEMIA MISTA
2007-01-01 Fabris, M; DE MARCHI, G; DE VITA, Salvatore
Evidence for an association between the -871 t/c promoter polymorphism in the b-lymphocyte stimulator (blys) gene and the development of an overt lymphoproliferative disorder in mixed cryoglobulinemia syndrome (mcsn)
2007-01-01 Fabris, M; Lerussi, A; Quartuccio, Luca; De, Marchi; DE VITA, Salvatore
Development of type II mixed cryoglobulinaemic syndrome after effective and persistent hepatitis C virus eradication.
2007-01-01 Quartuccio, Luca; De Marchi, G.; Fabris, M.; DE VITA, Salvatore
Elevated B cell-activating factor of the tumour necrosis factor family in coeliac disease
2007-01-01 Fabris, M; Visentini, D; De Re, V; Picierno, A; Maieron, R; Cannizzaro, R; Villalta, D; Curcio, Francesco; DE VITA, Salvatore; Tonutti, E.
Bone marrow B-cell clonal expansion in type II mixed cryoglobulinaemia: Association with nephritis RID A-8026-2008
2007-01-01 Quartuccio, Luca; Fabris, M; Salvin, S; Isola, Miriam; Soldano, F; Falleti, E; Beltrami, Ca; De Re, V; DE VITA, Salvatore
B-Lymphocyte Stimulator (BLyS) upregulation in mixed cryoglobulinemia syndrome and hepatitis C virus infection
2007-01-01 Fabris, M.; Quartuccio, Luca; Sacco, S.; De Marchi, G.; Pozzato, G.; Mazzaro, C.; Ferraccioli, G.; Migone, T.; DE VITA, Salvatore
Safety of Rituximab in different rheumatic autoimmune diseases. A single centre experience in 85 cases. 2008
2008-01-01 Quartuccio, Luca; Fabris, M; Sacco, S; Perin, A; Di Poi, E; DE VITA, Salvatore
Safety of Rituximab in different rheumatic autoimmune diseases. A single centre experience in 85 cases.
2008-01-01 Quartuccio, Luca; Fabris, M; Sacco, S; Perin, A; Di Poi, E; DE VITA, Salvatore
Resistance to Rituximab Therapy and Local BAFF Overexpression in Sjögren's Syndrome-Related Myoepithelial Sialadenitis and Low-Grade Parotid B-Cell Lymphoma
2008-01-01 Quartuccio, Luca; Fabris, M; Moretti, M; Barone, F; Bombardieri, M; Rupolo, M; Lombardi, S; Pitzalis, C; Beltrami, Ca; Curcio, Francesco; DE VITA, Salvatore
Fibronectin gene polymorphisms and clinical manifestations of mixed cryoglobulinemic syndrome: increased risk of lymphoma associated to MspI DD and HaeIII AA genotypes
2008-01-01 Fabris, M; Quartuccio, Luca; De Re, V; Pozzato, G; Mazzaro, C; Tavoni, A; Ferri, C; Salvin, S; Lerussi, A; Fabro, C; Bombardieri, S; DE VITA, Salvatore
Disappearance of bone marrow B cell clonal expansion in patients with type II hepatitis C virus-related cryoglobulinemic glomerulonephritis after clinical efficient rituximab therapy.
2008-01-01 DE VITA, Salvatore; Fabris, M.; Quartuccio, Luca; Sacco, S.; Salvin, S.
Hepatitis C virus infection, mixed cryoglobulinemia and BLyS upregulation: targeting the infectious trigger, the autoimmune response, or both?
2008-01-01 DE VITA, Salvatore; Quartuccio, Luca; Fabris, M.
Fibronectin gene polymorphisms are associated with the development of B-cell lymphoma in type II mixed cryoglobulinemia.
2008-01-01 Baldini, C; DE RE, V; DE VITA, Salvatore; Fabris, M; Ferri, C; Mazzaro, C; Pozzato, G; Quartuccio, Luca; Salvin, S.
BLYS Promoter Polymorphins and Response to Rituximab in Rheumatoid Arthritis (RA) patients positive or negative for Rheumatoid Facto
2009-01-01 Fabris, M; Quartuccio, Luca; Saracco, M; Pellerito, R; Atzeni, F; Scarzi Puttini, P.
Rankl and osteoprotegerin serum levels changes after rituximab therapy in rheumatoid arthritis: correlation with disease control and bone mineral density preservation
2009-01-01 Fabris, M; Salvin, S; Tonutti, E; Quartuccio, Luca; Lerussi, A; Fabro, C.
USE OF THE SEROLOGICAL ASSAY OF THE CYTOKINE B-LYMPHOCYTE STIMULATOR (BLYS) FOR THE DIAGNOSIS, PROGNOSIS AND THE SCREENING OF THERAPEUTIC EFFICACY IN IMMUNE-RELATED DISEASES INCLUDING ORGAN-SPECIFIC AUTOIMMUNE DISEASES AND TRANSFUSION REACTIONS
2009-01-01 Curcio, Francesco; DE VITA, Salvatore; Fabris, M; Tonutti, E; Melli, C.
prevalence of chlamydophila psittaci subclinical infection in italian patients with rheumatoid arthritis: etiopathological and therapeutic implications
2009-01-01 Fabris, M; Pasini, E; Lombardi, S; Fabro, C; Bolzan, C; Quartuccio, Luca
Rheumatoid factor positivity, a lower disability and a lower number of anti-tnf agents failed are associated with response to rituximab in rheumatoid arthritis
2009-01-01 Quartuccio, Luca; Salvin, S; Fabris, M; Atzeni, F; Sarzi Puttini, P; Saracco, M; Pellerito, R; Benucci, M; Cimmino, M; Cutolo, M; DE VITA, Salvatore
Rheumatoid factor positivity, a lower disability and a lower number of anti-tnf agents failed are associated with response to rituximab in rheumatoid arthritis
2009-01-01 Quartuccio, Luca; S., Salvin; M., Fabris; F., Atzeni; P., Sarzi Puttini; M., Saracco; R., Pellerito; M., Benucci; M., Cimmino; M., Cutolo; DE VITA, Salvatore
Blys Promoter Polymorphism And Response To Rituximab In Rheumatoid Arthritis (RA) Patients Positive Or Negative For The Rheumatoid Factor
2009-01-01 Fabris, M; Quartuccio, Luca; Saracco, M; Pellerito, R; Atzeni, F; Sarzi Puttini, P.
Controversies on rituximab therapy in Sjögren's syndrome-associated lymphoproliferation
2009-01-01 Quartuccio, Luca; Fabris, M; Salvin, S; Maset, M; De Marchi, G; DE VITA, Salvatore
BlYS Promoter Polymorphins and Response to Rituximab in Rheumatoid Arthritis (RA) patients positive or negative for Rheumatoid Factor, , vol 60 suppl 10 :1678
2009-01-01 M., Fabris; Quartuccio, Luca; M., Saracco; R., Pellerito; F., Atzeni; P., Scarzi Puttini; M., Cimmino; M., Benucci; C., Fabro; P., Morassi; M., Bolzan; F., Fischetti; DE VITA, Salvatore
Long-Term Effects of Rituximab in Rheumatoid Arthritis Clinical, Biologic, and Pharmacogenetic Aspects
2009-01-01 Quartuccio, Luca; Lombardi, S; Fabris, M; Masolini, P; Saracco, M; Pellerito, R; DE VITA, Salvatore
B-lymphocyte stimulator and a proliferation-inducing ligand serum levels in IgA-deficient patients with and without celiac disease
2009-01-01 Fabris, M.; De Vita, S.; Visentini, D.; Fabro, C.; Picierno, A.; Lerussi, A.; Villalta, D.; Alessio, M. G.; Tampoia, M.; Tonutti, E.
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile